Clinical Trials in Detroit

Showing 8921-8940 of 19,719 trials

Citalopram for Sx/Util in Acute Coronary Syndrome Patients

NCT01667744

Symptoms (chest pain, shortness of breath, dizziness, etc.) and treatment usage (doctor or emergency room visits, testing, hospital days, etc.) in patients with Acute Coronary Syndromes are known to be related to emotional distress (Anxiety, Depression and Anger). In addition, behavioral treatment of emotional distress is known to decrease symptoms, and treatment usage. The present protocol tests whether the addition of a medication known to reduce emotional distress can also reduce symptoms and treatment usage. This will done by recruiting patients with ACS during their hospital stay, randomizing them to receive citalopram or placebo, and then examining their symptoms and treatment usage at 6 months.

Acute Coronary Syndrome

Henry Ford Health SystemStarted Jan 2016

Detroit, Michigan, United States

COMPLETEDNA< 1 mile

Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)

NCT02081248

The study has two parts: (1) Randomized Study to evaluate the effectiveness of ETRIC, and (2) Evaluation Study to understand barriers to implementation of ETRIC.

Improve the Informed Consent Process

Medical College of Wisconsin198 participantsStarted Dec 2013

Duarte, California, United States • Gainesville, Florida, United States • Orlando, Florida, United States +20 more locations

Citalopram for Sx/Util in Acute Coronary Syndrome Patients

Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN 1205)

Find Trials by Condition in Detroit

Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction

Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma

Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

The International Diabetes Closed Loop (iDCL) Trial: Protocol 4

DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory